与阿尔茨海默氏症相关的质和神经细胞变化在人类诱导的多能干细胞中复制,具有前列林林-1突变
Research square
|February 6, 2026
概括
使用人类干细胞的阿尔茨海默病 (AD) 模型显示,质细胞显示功能改变和炎症标志物. 当神经元和细胞质都携带AD突变时,神经元损伤是严重的.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 干细胞研究 干细胞研究
背景情况:
- 质细胞,包括星体细胞和微质细胞,在神经炎症中发挥着关键作用,这是阿尔茨海默氏症 (AD) 病原发生的关键因素.
- 了解质细胞激活及其在阿尔茨海默病中的特异性特征对于开发有效的治疗策略至关重要.
- 人类诱导的多能干细胞 (iPSCs) 提供了一个强大的平台来模拟人类特异性的AD细胞变化.
研究的目的:
- 为了研究与阿尔茨海默氏病相关的微质细胞和由具有PSEN1突变的iPSCs衍生的星球细胞的损伤.
- 为了确定这些质细胞改变对神经元退化的贡献,在体外.
- 探索AD中神经元和神经质之间的神经病理通信.
主要方法:
- 使用孤立的质细胞培养物和来自携带 presenilin-1 (PSEN1) 突变的 iPSCs 的神经元/质细胞共培养物.
- 分析了微质细胞和天体细胞的功能性质,形态学和基因表达.
- 在共同培养模型中评估神经元网络完整性,突触功能和电生理学特性.
主要成果:
- AD iPSC衍生的微质体表现出功能受损,而星球细胞显示出类似纤维细胞的表型,炎症标志物增加.
- 转录组分析区分了AD天体细胞与对照细胞,与观察到的形态变化相关.
- 质细胞特异性AD变化影响了神经元特性,当神经元和质细胞携带突变时,观察到剧烈的神经元损伤.
结论:
- 在IPSC衍生的体外模型中成功复制了关键的AD相关的细胞变化.
- 提供了对AD中脑细胞之间复杂的神经病理通信的新见解.
- 建立了iPSC衍生模型,作为研究AD机制和开发神经保护治疗的有希望的工具.
更多相关视频
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
11:52Establishment of an Electrophysiological Platform for Modeling ALS with Regionally-Specific Human Pluripotent Stem Cell-Derived Astrocytes and Neurons
Published on: August 26, 2021
相关概念视频
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...